参芎葡萄糖注射液联合低分子肝素治疗急性脑梗死临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R743.33

基金项目:


Clinical Study on Senate Ligusticum Glucose Injection Combined with Low Molecular Weight Heparin for Acute Cerebral Infarction
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察参芎葡萄糖注射液联合低分子肝素治疗急性脑梗死(ACI) 的临床疗效。方法:按照 随机数字表法将63 例ACI 患者分为A 组31 例与B 组32 例。A 组采用低分子肝素治疗,B 组在A 组基础上联 合参芎葡萄糖注射液治疗。2 组均治疗15 d。比较2 组治疗前后中医证候积分、大脑平均血流速度、Barthel 指 数和美国国立卫生研究院卒中量表(NIHSS) 评分,比较2 组临床疗效和不良反应。结果:B 组总有效率 96.88%,高于A 组77.42%(P<0.05)。治疗前,2 组中医证候积分比较,差异无统计学意义(P>0.05)。治疗 后,2 组头晕目眩、半身不遂、偏身麻木、舌苔白腻中医证候积分均降低(P<0.05),且B 组低于A 组(P< 0.05)。治疗前,2 组Barthel 指数、NHISS 评分比较,差异无统计学意义(P>0.05);治疗后,2 组Barthel 指 数评分升高(P<0.05),NHISS 评分降低(P<0.05),且B 组Barthel 指数评分高于A 组(P<0.05),NHISS 评分低于A 组(P<0.05)。治疗前,2 组大脑中动脉、前动脉和后动脉平均血流速度比较,差异均无统计学意 义(P>0.05);治疗后,2 组大脑中动脉、前动脉和后动脉平均血流速度均增大(P<0.05),且B 组大于A 组(P<0.05)。B 组不良反应总发生率低于A 组(χ2=6.907,P=0.009)。结论:参芎葡萄糖注射液联合低分子 肝素治疗ACI 患者疗效理想,能改善患者症状,提高其神经功能和生活质量,调节脑血流速度,更具安全性。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Senate Ligusticum Glucose Injection combined with low molecular weight heparin for acute cerebral infarction (ACI). Methods:A total of 63 cases of ACI patients were divided into the A group and the B group according to the random number table method,with 31 and 32 cases in each group respectively. The A group was treated with low molecular weight heparin, and the B group was treated with Senate Ligusticum Glucose Injection based on the treatment of the A group. Both two groups were treated for 15 days. Before and after treatment,traditional Chinese medicine (TCM) syndrome scores,average cerebral blood flow velocity,Barthel Index,National Institutes of Health Stroke Scale (NIHSS) scores were compared between the two groups. The clinical effects and adverse reactions were compared between the two groups. Results:The total effective rate was 96.88% in the B group, higher than that of 77.42% in the A group (P<0.05). Before treatment, there was no significant difference being found in the comparison of TCM syndrome scores between the two groups (P>0.05). After treatment, the TCM syndrome scores including giddy and dazzled, hemiplegia, hemianesthesia, and white greasy tongue coating in the two groups were decreased (P<0.05),and the scores in the B group were lower than those in the A group (P<0.05). Before treatment, there was no significant difference being found in the comparison of scores of Barthel Index and NIHSS between the two groups (P>0.05). After treatment, scores of Barthel Index in the two groups were increased when compared with those before treatment (P<0.05),NHISS scores were decreased (P<0.05);the score of Barthel Index in the B group was higher than that in the A group (P<0.05), and the NIHSS score was lower than that in the A group (P<0.05). Before treatment, there was no significant difference being found in the comparison of mean blood velocity of middle artery, anterior artery, and posterior artery between the two groups (P> 0.05). After treatment,the mean blood velocity of middle artery,anterior artery,and posterior artery in the two groups were increased (P<0.05),and the ones in the B group were larger than those in the A group (P<0.05). The total incidence of adverse reactions in the B group was lower than that in the A group (χ 2= 6.907,P=0.009). Conclusion:The combination of Senate Ligusticum Glucose Injection and low molecular weight heparin has an ideal curative effect on ACI patients, which can improve symptoms, neurological function and quality of life,and regulate cerebral blood flow velocity,which is safer.

    参考文献
    相似文献
    引证文献
引用本文

杨俊,葛翡蕾,樊延强,金小璐.参芎葡萄糖注射液联合低分子肝素治疗急性脑梗死临床研究[J].新中医,2023,55(17):81-85

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-09-07
  • 出版日期:
文章二维码